Germany · Delayed Price · Currency is EUR PCI Biotech Holding ASA Statistics
Total Valuation
FRA:4QG has a market cap or net worth of EUR 887,769. The enterprise value is -244,942.
| Market Cap | 887,769 |
| Enterprise Value | -244,942 |
Important Dates
The last earnings date was Tuesday, November 18, 2025.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 37.33M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | -0.41% |
| Owned by Insiders (%) | 8.86% |
| Owned by Institutions (%) | 22.41% |
| Float | 28.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.25 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.18 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.94 |
| Quick Ratio | 2.94 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -206.03 |
Financial Efficiency
Return on equity (ROE) is -92.47% and return on invested capital (ROIC) is -59.86%.
| Return on Equity (ROE) | -92.47% |
| Return on Assets (ROA) | -48.34% |
| Return on Invested Capital (ROIC) | -59.86% |
| Return on Capital Employed (ROCE) | -172.86% |
| Revenue Per Employee | 78,919 |
| Profits Per Employee | -345,742 |
| Employee Count | 5 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.58% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -84.58% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 39.16 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:4QG had revenue of EUR 394,595 and -1.73 million in losses. Loss per share was -0.05.
| Revenue | 394,595 |
| Gross Profit | 394,595 |
| Operating Income | -1.82M |
| Pretax Income | -1.73M |
| Net Income | -1.73M |
| EBITDA | -1.78M |
| EBIT | -1.82M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 1.15 million in cash and 23,736 in debt, giving a net cash position of 1.12 million.
| Cash & Cash Equivalents | 1.15M |
| Total Debt | 23,736 |
| Net Cash | 1.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.05M |
| Book Value Per Share | 0.03 |
| Working Capital | 981,521 |
Cash Flow
In the last 12 months, operating cash flow was -1.33 million and capital expenditures -53,112, giving a free cash flow of -1.38 million.
| Operating Cash Flow | -1.33M |
| Capital Expenditures | -53,112 |
| Free Cash Flow | -1.38M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -461.45% |
| Pretax Margin | -438.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:4QG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | -194.73% |
| FCF Yield | -155.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |